Celldex Therapeutics (CLDX) Price to Sales (2011 - 2026)
Celldex Therapeutics' (CLDX) Price to Sales stood at 18487.29 in Q2 2026, compared with 233.31 a year earlier and up 658.2% from the prior quarter.
Powered by 
Analysis
Celldex Therapeutics (CLDX) Price to Sales (2011 - 2026) Analysis & Trends
For FY2025, Celldex Therapeutics' Price to Sales came in at 1169.89, up 389.6% from FY2024.
- Across earlier years, Price to Sales came in at 238.93 in FY2024 (-25.8%), 322.00 in FY2023 (-63.9%), 892.55 in FY2022 (+129.9%) and 388.23 in FY2021 (+454.6%).
- The Q2 2026 figure is the highest quarterly Price to Sales in data going back to Q1 2011.
- On a year-over-year basis, Price to Sales rose in two of the last six quarters, with growth averaging 74.3%.
- Peak year-over-year performance for Price to Sales in the last five years was growth of 895.5% in Q2 2022, against a decline of 75.7% in Q3 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at 2438.30 (Q1 2026), 1169.14 (Q4 2025) and 661.15 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn |
| 10 | Celldex Therapeutics | 2.53 Bn | 2.53 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18,487.29 |
| Mar 31, 2026 | 2,438.30 |
| Dec 31, 2025 | 1,169.14 |
| Sep 30, 2025 | 661.15 |
| Jun 30, 2025 | 233.31 |
| Mar 31, 2025 | 159.40 |
| Dec 31, 2024 | 238.93 |
| Sep 30, 2024 | 226.05 |
| Jun 30, 2024 | 295.48 |
| Mar 31, 2024 | 455.58 |
| Dec 31, 2023 | 322.00 |
| Sep 30, 2023 | 297.99 |
| Jun 30, 2023 | 492.57 |
| Mar 31, 2023 | 539.64 |
| Dec 31, 2022 | 892.55 |
| Sep 30, 2022 | 1,228.08 |
| Jun 30, 2022 | 1,530.07 |
| Mar 31, 2022 | 384.56 |
| Dec 31, 2021 | 388.15 |
| Sep 30, 2021 | 310.88 |
API Access
Celldex Therapeutics Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=CLDX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "CLDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=CLDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();